Call us today! +86 21 5132 0088
Since founded in 2007, extensive ADME profiling (>80,000) and PK& Exploratory Toxicology studies (>10,000) have been conducted to support numerous drug discovery and development programs with worldwide partners. Working closely with internal Biology, Pharmacology and Antibody Engineering teams, ChemPartner DMPK group supports translational medicine through our expertise in formulation development, in vitro-in vivo extrapolation, PK/PD modeling, biomarker analysis and metabolomics. We take pride in our work and view our partners’ success as our success.